Drospirenone
Back to searchMolecule Structure
Scientific Name
Drospirenone
Description of the Drug
Drospirenone is a progestin used in oral contraceptive pills for the prevention of pregnancy and other conditions.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB01395
http://www.drugbank.ca/drugs/DB01395
Brand Name(s)
Angeliq, Slynd
Company Owner(s)
Exeltis Usa Inc, Apotex Inc, Mylan Laboratories Ltd, Healthcare Pharmaceuticals Ltd, Sun Pharmaceutical Industries Ltd, Novast Laboratories Ltd, Watson Laboratories Inc, Naari Pte Ltd, Hetero Labs Ltd, Xiromed Pharma Espana Sl
Mechanism(s) Of Action
| Target Name | Target Type | Action Type | Target ChEMBL ID |
|---|---|---|---|
| Mineralocorticoid receptor | SINGLE PROTEIN | ANTAGONIST | CHEMBL1994 |
| Progesterone receptor | SINGLE PROTEIN | AGONIST | CHEMBL208 |
Clinical Trial(s)
Unichem Links
| SureChEMBL | SCHEMBL153316 | |
| PharmGKB | PA164749409 | |
| Human Metabolome Database | HMDB0015467 | |
| DrugBank | DB01395 | |
| PubChem: Thomson Pharma | 14828606 | 14828605 |
| PubChem | 68873 | |
| NMRShiftDB | 60061386 | |
| Nikkaji | J310.243B | |
| BindingDB | 150275 | |
| EPA CompTox Dashboard | DTXSID7046465 | |
| DrugCentral | 968 | |
| Brenda | 217229 | |
| ChemicalBook | CB8695608 | |
| Guide to Pharmacology | 2874 | |
| rxnorm | DROSPIRENONE | |
| PubChem: Drugs of the Future | 12014580 | |
| ChEBI | 50838 | |
| ZINC | ZINC000003927200 |
